WIGGINS MARK C 4
4 · Tracon Pharmaceuticals, Inc. · Filed Dec 30, 2020
Insider Transaction Report
Form 4
WIGGINS MARK C
Chief Business Officer
Transactions
- Purchase
Common Stock
2020-12-29$10.56/sh+3$32→ 13,700 total - Purchase
Common Stock
2020-12-29$10.57/sh+997$10,538→ 13,697 total
Footnotes (1)
- [F1]Includes 350 shares acquired by the reporting person under the Issuer's 2015 Employee Stock Purchase Plan on October 20, 2020.